Rockefeller Capital Management L.P.
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 1739439
NEW YORK, NY
Position in ENTA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$32,369
+$24,264 QoQ
Shares Held
2,563
+398.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $285,796,172 across 243 Biotechnology names. ENTA ranks #120 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
149,655 | $66,826,941 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
249,174 | $47,106,343 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
384,672 | $26,207,702 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
1,027,357 | $22,868,965 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,520 | $22,035,691 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
372,197 | $21,025,406 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
33,849 | $17,718,934 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
123,497 | $4,978,162 |
All Filings in ENTA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,369 | 2,563 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,105 | 514 | Shares | Defined | 2026-03-17 | |
| No filing history on record for this holder in this stock. | ||||||